Navigation Links
Patent Issued for e-Smart Technologies, Inc.'s First Biometric Match-on-Card Technology
Date:11/5/2007

NEW YORK, Nov. 5 /PRNewswire-FirstCall/ -- e-Smart Technologies, Inc. (Pink Sheets: ESMT); ("e-Smart") with its parent company IVI Smart Technologies, Inc. ("IVI") (hereinafter, collectively the "Company") is pleased to announce that the United States Patent and Trademark Office has issued a patent for the Company's cutting edge, intelligent biometric identification card technology.

On October 2, 2007, the United States Patent and Trademark Office issued Patent No. 7,278,025, entitled "Secure Biometric Verification of Identity," to e-Smart's parent corporation, IVI Smart Technologies, which has licensed the use of the technology to e-Smart. The patent encompasses 27 separate claims relating to numerous aspects of the technology, including patent protection for our "intelligent identification card comprising an on-board sensor for capturing live biometric data" and an "on-board processor including a memory storing reference data" which "compares the captured data with the stored data and generates a verification message if there is a match within a predetermined threshold."

The patent also covers the Company's method for capturing the biometric data and matching that captured data with reference data, and causing the card to perform a desired function only if the identity of the user is verified.

Tamio Saito, Chief Technology Officer and lead inventor, said "I am filled with great pride and satisfaction at this acknowledgement of the years of work of e-Smart's talented team of engineers. We dedicated years to the development of e-Smart's state-of-the-art identification and payment security system, and the Super Smart Card,(TM) and now we can begin its deployment on a worldwide scale to protect people and secure countries with the confidence and security of patent protection for our inventions. "

Mary Grace, Chief Executive Officer of e-Smart, said "This is a great milestone for the Company. Years of hard work went into the development o
'/>"/>

SOURCE e-Smart Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology news :

1. bioMETRX, Inc. Acquires Patent for Biometric Padlock
2. bioMETRX, Inc. Acquires Patent for Biometric Padlock
3. Parus Interactive Awarded Patent for Speech-Activated Remote System Management
4. Which came first, the moth or the cactus?
5. First all-African GM crop is resistant to maize streak virus
6. Scientists retrace evolution with first atomic structure of an ancient protein
7. CU-Boulder team discovers first ancient manioc fields in Americas
8. First finding of a metabolite in 1 sex only
9. First orchid fossil puts showy blooms at some 80 million years old
10. First individual genome sequence published
11. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...s inspired a 3.2m, three-year research project tha...security, energy and the environment. The Universi...QinetiQ have just signed a collaborative contract ...g physical sciences research. , Over the next t...y of Exeter and QinetiQ will work together to deve...
(Date:11/9/2009)...09 / b3c newswire / - Today, TNO, a Dutch contr...erican organization for contract research and cons... letter of intent with regard to TNOs dynamic in ...intent proposes a collaboration in which Seventh W...ion in North America. The TIM systems will be used...
(Date:11/9/2009)...leaders from around the world will gather in Bosto...ar Targets and Cancer Therapeutics International C...mation on important cancer therapies in developmen...it effectively we need a greater understanding of ...el," said Lewis Cantley, Ph.D., director of the ca...
Breaking Biology News(10 mins):£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Exponent to Announce Second Quarter 2009 Results 51709 1Elton John Billy Crystal Tony Bennett and Gladys Knight Help Starkey Hearing Foundation Raise More than 245 Million at Annual Fundraiser 51705 1Elton John Billy Crystal Tony Bennett and Gladys Knight Help Starkey Hearing Foundation Raise More than 245 Million at Annual Fundraiser 51705 2Elton John Billy Crystal Tony Bennett and Gladys Knight Help Starkey Hearing Foundation Raise More than 245 Million at Annual Fundraiser 51705 3Reminders Boost Mammography Appointments 51703 1Reminders Boost Mammography Appointments 51703 2
...ls have been little more than electronic versions ...the launch of PLoS ONE, which publishes primary re...pre- and post-publication peer review to maximize ...is published by the Public Library of Science (PLo...e the world,s scientific and medical literature a ...
...Many of them had narrow, pointed teeth, which were...wing them. But how did they then grind their food?... they were helped by stones which they swallowed. ...nd of ,gastric mill,. But this assumption does not...ties of Bonn and Tübingen have now proved. Their r...
... based on a combination of satellite data, compute...moke from Alaskan and Canadian forest fires as muc... away in Houston during a two-day period in July 2...in the Journal of Geophysical Research, offers sci...effects from pollutants generated thousands of mil...
Other Biology News:PLoS ONE is launched by the Public Library of Science 2PLoS ONE is launched by the Public Library of Science 3Dinosaurs -- stones did not help with digestion 2Dinosaurs -- stones did not help with digestion 3NASA study: Alaskan fires affected Houston air quality in 2004 2NASA study: Alaskan fires affected Houston air quality in 2004 3
(Date:11/6/2009)...G VALLEY, Calif., Nov. 6 Calbiotec... Small Business Innovative Research (SBIR) Phase I...terial command. Under terms of the agreement, Calb...s) for the diagnosis of Dengue virus. ,, Den...sents a major threat to military forces deployed t...
(Date:11/5/2009)...ERSBURG, Md., Nov. 5 Gen...ancial results for the third quarter ended Septemb...llion ($0.04 per share) for the three months ended... million ($0.08 per share) in the comparable quart..., 2009, GenVec,s net loss was $14.1 million ($0.15...
(Date:11/5/2009)...rence Call on Thursday, November 5, 2009 at 4:30 p...Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Pharmace...AQ: OGXI ) today reported unaudited financial res...eptember 30, 2009 and reviewed the Company,s highl...lowing consolidated results reflect the operations...
(Date:11/5/2009)...IEGO, CA, November 5, 2009 /PRNewswire-FirstCall/ ...ed on using proprietary taste receptor-based techn...he food, beverage, and ingredient supply industrie...financial results for the third quarter ended Sept...e third quarter of 2009, compared to $4.0 million ...
Breaking Biology Technology:Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
...nference Call Tomorrow (Tuesday) at 8:30 am EDT to... Valley Cottage, NEW YORK, September 10 XTL,Biop...E: XTL) today announced,the initiation of a Phase ... norepinephrine reuptake inhibitor (SNRI) - for th...ine is being developed for the treatment of diabet...
...ltern, a leading global research,organization, is ...,Chiltern,s Country Manager for the Czech Republic...e year award. The award ceremony was held in,Londo...om amongst his peers by a panel of judges who,revi...ccessful conclusion,of clinical trials. The judgin...
Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
Other Biology Technology:XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 2XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 3XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 4XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 5XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 6XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 7Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year 2
Fingerprinting II Database Sharing Tools from Bio-Rad
Fingerprinting II Identification and Library Manager from Bio-Rad
DNA Engine Opticon 2 Continuous Fluorescence Detection System from Bio-Rad
...High Quality, Functionally-Validated, Ion Channel ...ng a critical role in nerve and muscle function an...d the heart. Drugs that modulate ion channels have...europathic pain, cardiac arrhythmia, hypertension,...
Biology Products: